technetium has been researched along with paclitaxel in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbruzzes, J; Azhdarinia, A; Bryant, JL; Fogler, WE; Herbst, R; Kalimi, SK; Kim, EE; Kim, KD; Ozaki, K; Podoloff, DA; Roach, JS; Schechter, NR; Wu, P; Yang, DJ; Yu, DF | 1 |
| Bae, JS; Chi, DY; Choe, YS; Jung, KH; Kim, DH; Ko, BH; Lee, BC; Lee, KH; Paik, JY; Sung, HJ | 1 |
| Broemeling, L; Gong, J; Humphreys, R; Kohanim, S; Kurzrock, R; Yang, D | 1 |
| Fan, KW; Fang, W; Ji, SD; Li, Y; Meng, QL; Wang, F; Wang, ZZ | 1 |
| Fang, W; Ji, S; Li, Y; Wang, F; Wang, Z; Zhao, M; Zheng, Y | 1 |
| Benoit, JP; Garcion, E; Hindré, F; Paillard, A; Vignes-Colombeix, C | 1 |
| Jain, NK; Jain, V; Kaul, A; Mishra, AK; Mishra, PR; Swarnakar, NK; Verma, A | 1 |
| Ari, K; Ichedef, C; Kilcar, AY; Medine, EI; Parlak, Y; Sayit Bilgin, BE; Teksoz, S; Ucar, E; Unak, P | 1 |
| Cardoso, VN; de Barros, ALB; Fernandes, RS; Leite, EA; Lopes, SC; Monteiro, LOF; Oda, CMR; Oliveira, MC; Rubello, D; Townsend, DM | 1 |
| Dogan, T; Kilcar, AY; Muftuler, FZB; Sulu, E; Takan, G; Yildiz, O | 1 |
10 other study(ies) available for technetium and paclitaxel
| Article | Year |
|---|---|
Assessment of antiangiogenic effect using 99mTc-EC-endostatin.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Collagen; Cysteine; Endostatins; Endothelial Growth Factors; Female; Fibroblast Growth Factor 2; In Situ Nick-End Labeling; Intercellular Signaling Peptides and Proteins; Interleukin-8; Lymphokines; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Paclitaxel; Peptide Fragments; Radionuclide Imaging; Rats; Rats, Inbred F344; Technetium; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Fibrosarcoma; Humans; Kinetics; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Organ Specificity; Paclitaxel; Radionuclide Imaging; Radiopharmaceuticals; Rats; Technetium; Tissue Distribution; Treatment Outcome | 2006 |
Novel in vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Colorectal Neoplasms; Drug Synergism; Female; Humans; Indium Radioisotopes; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Paclitaxel; Phosphorylation; Radionuclide Imaging; Receptors, TNF-Related Apoptosis-Inducing Ligand; Technetium; Tumor Suppressor Protein p53; Up-Regulation; Xenograft Model Antitumor Assays | 2006 |
[Technetium-99m labeled synaptotagmin I C2A detection of paclitaxel-induced apoptosis in non-small cell lung cancer].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Flow Cytometry; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Synaptotagmin I; Technetium; Xenograft Model Antitumor Assays | 2007 |
Imaging paclitaxel (chemotherapy)-induced tumor apoptosis with 99mTc C2A, a domain of synaptotagmin I: a preliminary study.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; Disease Models, Animal; DNA Fragmentation; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Mice; Paclitaxel; Protein Structure, Tertiary; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Synaptotagmin I; Technetium; Tissue Distribution | 2008 |
The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
Topics: Animals; Cell Line, Tumor; Cells, Cultured; Cholesterol; Drug Carriers; Flow Cytometry; Lecithins; Lysosomes; Microscopy, Confocal; Nanocapsules; Nanotechnology; Paclitaxel; Rats; Signal Transduction; Surface-Active Agents; Technetium; Triglycerides | 2010 |
Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cryoelectron Microscopy; Crystallization; Drug Carriers; Drug Delivery Systems; Female; Glycerides; Hemolysis; Liquid Crystals; Male; Mice; Nanoparticles; Nanotechnology; Paclitaxel; Polyethylene Glycols; Rabbits; Rats; Scattering, Radiation; Technetium; Time Factors | 2012 |
Synthesis, characterization and radiolabeling of folic acid modified nanostructured lipid carriers as a contrast agent and drug delivery system.
Topics: A549 Cells; Animals; Contrast Media; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; HeLa Cells; Humans; Lipids; MCF-7 Cells; Microscopy, Fluorescence; Nanostructures; Paclitaxel; Rats; Rats, Wistar; Technetium; Tissue Distribution | 2017 |
Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Technetium; Tissue Distribution | 2018 |
The Effect of Bitter Melon (Momordica charantia) Extract on the Uptake of
Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Female; Humans; Momordica charantia; Paclitaxel; Plant Extracts; Technetium; Tumor Cells, Cultured | 2020 |